Market Overview - The Shanghai Composite Index closed at 3739.26 points, above the annual line, with a change of 0.30% [1] - The total trading volume of A-shares reached 16780.81 billion yuan [1] Stocks Breaking Annual Line - A total of 38 A-shares have broken above the annual line today, with notable stocks including Chengmai Technology, ST Xiangxue, and Huali Co., with deviation rates of 19.19%, 11.40%, and 4.94% respectively [1] - Stocks with smaller deviation rates that just crossed the annual line include Hangzhou Thermal Power, ShuiJinFang, and Jian Design [1] Top Stocks by Deviation Rate - Chengmai Technology (300598) saw a price increase of 20.00% with a turnover rate of 15.15%, latest price at 55.39 yuan, deviation rate of 19.19% [1] - ST Xiangxue (300147) increased by 15.83% with a turnover rate of 7.20%, latest price at 10.17 yuan, deviation rate of 11.40% [1] - Huali Co. (603038) rose by 7.34% with a turnover rate of 8.87%, latest price at 15.51 yuan, deviation rate of 4.94% [1] Additional Stocks with Notable Performance - Other stocks with significant performance include *ST Xinyuan (300472) with a 6.57% increase and a deviation rate of 4.21% [1] - Jiutian Pharmaceutical (300705) increased by 3.77% with a deviation rate of 3.57% [1] - Guodian Power (600795) rose by 5.10% with a deviation rate of 3.54% [1]

Market Performance - As of August 18, the Shanghai Composite Index closed at 3728.03 points, with a change of +0.85% [1] - The Shenzhen Component Index closed at 11835.57 points, with a change of +1.73% [1] - The ChiNext Index closed at 2606.20 points, with a change of +2.84% [1] Trading Volume Analysis - A total of 3145 stocks saw an increase in average transaction volume, with 69 stocks experiencing an increase of over 50% [1] - Notable stocks with significant increases in average transaction volume include Hengshen New Materials (+230.41%), Changyuan Donggu (+166.68%), and Furuide (+166.49%) [1] - Conversely, 1407 stocks experienced a decrease in average transaction volume [1] Active Stocks by Transaction Count - The stocks with the highest increase in transaction count include Quzhou Development (+6673.62%), Huakong Saige (+585.39%), and Guanshi Technology (+563.59%) [2] - Other notable stocks with significant increases in transaction count are ST Xiangxue (+557.96%) and Shangrong Medical (+554.81%) [2] Stocks with Both Volume and Count Increases - City Media reported a daily change of +7.24%, with both average transaction volume and transaction count increasing by over 50% [3] - Huazhi Digital Media showed a daily change of +20.02%, with a significant increase in transaction count by +469.66% [4] - Other stocks with notable increases in both metrics include Yunnan Energy Investment (+9.98%) and Tianchuang Fashion (+1.94%) [4]

证券之星消息，8月18日中药板块较上一交易日上涨1.24%，ST香雪领涨。当日上证指数报收于3728.03， 上涨0.85%。深证成指报收于11835.57，上涨1.73%。中药板块个股涨跌见下表： 从资金流向上来看，当日中药板块主力资金净流出2.32亿元，游资资金净流入3178.63万元，散户资金净 流入2.01亿元。中药板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入(元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002873 新天药业 | | 1.28亿 | 18.61% | -6088.75万 | -8.82% | -6760.47万 | -9.79% | | 600436 | 片仔瘦 | 1.05 Z | 9.11% | -8305.93万 | -7.21% | -2190.81万 | -1.90% | | 600557 康缘药业 | | 7471.52万 | 12.77% | -4239.39万 | -7.25% | -323 ...

Market Overview - The Shanghai Composite Index closed at 3740.50 points, above the six-month moving average, with an increase of 1.18% [1] - The total trading volume of A-shares reached 17,467.28 million yuan [1] Stocks Breaking the Six-Month Moving Average - A total of 187 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Jingsai Technology (27.02%) - Haidaer (25.37%) - Huazhi Shumedia (16.28%) [1] Stocks with Smaller Deviation Rates - Stocks that have just crossed the six-month moving average with smaller deviation rates include: - Tianfang Biao - Anning Co. - Tianwei Foods [1] Performance of Selected Stocks - Jingsai Technology: Today's increase of 29.98%, turnover rate of 23.53%, six-month average price of 36.65 yuan, latest price of 46.56 yuan [1] - Haidaer: Today's increase of 30.00%, turnover rate of 24.95%, six-month average price of 47.67 yuan, latest price of 59.76 yuan [1] - Huazhi Shumedia: Today's increase of 20.02%, turnover rate of 8.50%, six-month average price of 9.95 yuan, latest price of 11.57 yuan [1]

Market Performance - A-shares major indices rose, with the Shenzhen Component Index increasing over 1%, the ChiNext Index rising over 1%, and the Shanghai Composite Index up by 0.44% [1] - Concepts such as liquid cooling, AI corpus, Huawei HiSilicon, shipbuilding, and film and television showed strong performance, while precious metals, coal, and multi-financial concepts weakened [1] - Nearly 4,000 stocks in the market rose, while 1,100 stocks declined [1] Stock Highlights - ST Xiangxue (300147) saw a price increase of 16.47% with a total market value of 5.892 billion [2] - Hanyu Pharmaceutical (300199) increased by 12.05%, with a market cap of 25.8 billion and a year-to-date increase of 126.53% [2] - Wanbangde (002082) rose by 10.01%, with a market value of 4.906 billion and a year-to-date increase of 24.73% [2] - Tian Shili (600535) increased by 7.73%, with a market cap of 26 billion and a year-to-date increase of 22.17% [2] - Shanghai Leifu (688091) rose by 6.94%, with a market value of 16.9 billion and a year-to-date increase of 104.93% [2] - Olin Bio (688319) increased by 5.63%, with a market cap of 10.3 billion and a year-to-date increase of 139.06% [2] - Yangguang Nuohuo (688621) rose by 5.22%, with a market value of 9.033 billion and a year-to-date increase of 114.56% [2] - Other notable stocks include Nuo Si Lan De (430047) up by 4.62%, Hai Te Bio (300683) up by 4.08%, and Nanxin Pharmaceutical (688189) up by 4.08% [2]

Core Viewpoint - Xiangxue Pharmaceutical (300147.SZ) is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws, resulting in an administrative penalty [1] Summary by Relevant Categories Company Penalties - The company has been ordered to rectify its actions and received a warning, along with a fine of 6 million yuan [1] - The actual controller and former chairman, Wang Yonghui, was fined 10 million yuan, which includes 3 million yuan as the directly responsible supervisor and 7 million yuan as the actual controller [1] - The former CFO, Lu Feng, received a warning and a fine of 2 million yuan [1] Other Executive Penalties - Former directors and executives Huang Bin and Xu Li were each warned and fined 1 million yuan [1] - Former CFO Chen Binghua was warned and fined 150,000 yuan [1]

Group 1 - Company ST Xiangxue received an administrative penalty from the China Securities Regulatory Commission (CSRC) for false reporting in its 2019 annual report and failure to disclose non-operating fund occupation, resulting in a fine of 6 million yuan [1] - The actual controller Wang Yonghui was warned and fined 10 million yuan, but the company is not subject to major illegal delisting circumstances [1] - The company has restated its financial reports and cleared the non-operating fund occupation by Kunlun Investment, completing the necessary rectifications [1] Group 2 - The company is making positive progress in its judicial reorganization, with the Guangzhou Intermediate People's Court extending the pre-reorganization period to October 11, 2025 [2] - Ongoing work includes debt claim declaration and review, auditing, evaluation, and financial consulting, with selected intermediary institutions for assistance [2] - Successful reorganization is expected to improve the company's asset-liability structure and support sustainable development [2]

Core Viewpoint - ST Xiangxue (300147) has received an administrative penalty decision from the China Securities Regulatory Commission (CSRC) due to information disclosure violations, with some penalties being reduced compared to the prior notice [1] Regulatory Actions - The administrative penalty decision no longer imposes a 5-year market ban on the actual controller Wang Yonghui and removes the warning and 500,000 yuan fine against the former independent director Hao Shiming, while other penalties remain consistent with the prior notice [1] Corporate Restructuring - The Guangzhou Intermediate People's Court has agreed to extend the company's pre-restructuring period until October 11, 2025, during which the company will actively cooperate with the temporary administrator and the court [1] - The company has publicly appointed auditing, evaluation, and financial advisory intermediaries, with the auditing and evaluation work progressing smoothly [1] Business Operations - The company emphasizes the clinical value and market potential of TAEST16001 and is fully advancing the preparatory work for confirmatory clinical trials, with updates to be disclosed according to clinical developments and information disclosure rules [1]

证券代码:300147 证券简称: 香雪制药 公告编号:2025-038 广州市香雪制药股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 雪制药"）及公司实际控制人王永辉收到中国证券监督管理委员会（以下简称"中 国证监会"）下发的《立案告知书》（编号：证监会立案字 0062024028 号、编 号：证监会立案字 0062024029 号），因涉嫌信息披露违法违规，根据《中华人 民共和国证券法》、《中华人民共和国行政处罚法》等法律法规，中国证监会决 定对公司及王永辉立案。2025 年 3 月 21 日，公司收到中国证监会发出的《行政 处罚事先告知书》（广东证监处罚字〔2025〕5 号）。以上具体内容详见公司分 别于 2024 年 9 月 30 日、2025 年 3 月 21 日在巨潮资讯网披露的《关于公司及实 际控制人收到中国证券监督管理委员会立案告知书的公告》 （公告编号:2024-051） 和《关于公司及相关当事人收到 <行政处罚事先告知书> 的公告》 （公告编号:2025- 近日，公司及相关当事人收到中国证券监督管理委员会广东监管局发出的 《行 ...

证券代码:300147 证券简称: 香雪制药 公告编号:2025-038 广州市香雪制药股份有限公司 关于公司及相关当事人收到《行政处罚决定书》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 2024 年 9 月 30 日，广州市香雪制药股份有限公司（以下简称"公司"、"香 雪制药"）及公司实际控制人王永辉收到中国证券监督管理委员会（以下简称"中 国证监会"）下发的《立案告知书》（编号：证监会立案字 0062024028 号、编 号：证监会立案字 0062024029 号），因涉嫌信息披露违法违规，根据《中华人 民共和国证券法》、《中华人民共和国行政处罚法》等法律法规，中国证监会决 定对公司及王永辉立案。2025 年 3 月 21 日，公司收到中国证监会发出的《行政 处罚事先告知书》（广东证监处罚字〔2025〕5 号）。以上具体内容详见公司分 别于 2024 年 9 月 30 日、2025 年 3 月 21 日在巨潮资讯网披露的《关于公司及实 际控制人收到中国证券监督管理委员会立案告知书的公告》（公告编号:2024-051） 和《关于公司及相关当事人收 ...